Clinical Trial Update: Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)

View source ↗

Summary

A clinical trial update on analyzing immune cell infiltrates in psoriasis skin during treatment with an anti-IL-23 therapy. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Anti-IL-23 monoclonal antibody (anti-IL-23 monoclonal antibody)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Psoriasis | Status: RECRUITING